TrialClinical lung cancer2026

Efficacy of Neratinib-Based Therapy in ERBB2-Mutant Lung Adenocarcinomas: Findings From 2 International Phase 2 Studies.

Bob T Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.